nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Association of busulfan exposure with survival and toxicity after haemopoietic cell transplantation in children and young adults: a multicentre, retrospective cohort analysis
|
Bartelink, Imke H |
|
2016 |
3 |
11 |
p. e526-e536 nvt p. |
artikel |
2 |
Can we not bleed?
|
The Lancet Haematology, |
|
2016 |
3 |
11 |
p. e497- 1 p. |
artikel |
3 |
Child-onset and adolescent-onset acquired thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency: a cohort study of the French national registry for thrombotic microangiopathy
|
Joly, Bérangère S |
|
2016 |
3 |
11 |
p. e537-e546 nvt p. |
artikel |
4 |
Definition of functional iron deficiency and intravenous iron supplementation
|
Eisenga, Michele F |
|
2016 |
3 |
11 |
p. e504- 1 p. |
artikel |
5 |
Definition of functional iron deficiency and intravenous iron supplementation – Author's reply
|
Khalafallah, Alhossain A |
|
2016 |
3 |
11 |
p. e504-e505 nvt p. |
artikel |
6 |
Gilbert's syndrome in haemopoietic cell transplantation
|
Arora, Mukta |
|
2016 |
3 |
11 |
p. e500-e501 nvt p. |
artikel |
7 |
Mortality outcomes after busulfan-containing conditioning treatment and haemopoietic cell transplantation in patients with Gilbert's syndrome: a retrospective cohort study
|
McDonald, George B |
|
2016 |
3 |
11 |
p. e516-e525 nvt p. |
artikel |
8 |
Overall survival of patients with relapsed multiple myeloma treated with panobinostat or placebo plus bortezomib and dexamethasone (the PANORAMA 1 trial): a randomised, placebo-controlled, phase 3 trial
|
San-Miguel, Jesús F |
|
2016 |
3 |
11 |
p. e506-e515 nvt p. |
artikel |
9 |
Panobinostat plus bortezomib and dexamethasone for relapsed myeloma
|
Pratt, Guy |
|
2016 |
3 |
11 |
p. e498-e499 nvt p. |
artikel |
10 |
Standardising busulfan dosage for children and young adults
|
Gorin, Norbert-Claude |
|
2016 |
3 |
11 |
p. e502-e503 nvt p. |
artikel |